Increasing antibiotic resistance in clinical isolates of Aeromonas strains in Taiwan

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 5, 1996, Pages 1260-1262

  Ko, Wen Chien ^a   Yu, Kwok Woon ^b,c   Liu, Cheng Yi ^b   Huang, Ching Tai ^d   Leu, Hseih Shong ^d   Chuang, Yin Ching ^a,e  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d Department of Internal Medicine   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AZTREONAM; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; IMIPENEM; LATAMOXEF; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

AEROMONAS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRALIA; BACTERIUM ISOLATION; BLOOD CULTURE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; TAIWAN; UNITED STATES;

EID: 15844430234     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.5.1260     Document Type: Article

References (21)

1. Abbott, S. L., W. K. W. Cheung, S. Kroske-Bystorm, T. Matekzadeh, and J. M. Janda. 1992 Identification of Aeromonas strains to the genospecies level in the clinical laboratory. J Clin. Microbiol 30:1262-1266.
2. Carnahan, A., G. R. Fanning, and S. W. Joseph. 1991 Aeromonas jandaei (formerly genospecies DNA group 9 A. sobria), a new sucrose-negative species isolated from clinical specimens. J Clin. Microbiol. 29:560-564.
3. Chang, B. J., and S. M. Bolton. 1987. Plasmids and resistance to antimicrobial agents in Aeromonas sobna and Aeromonas hydrophila clinical isolates. Antimicrob. Agents Chemother. 31:1281-1282.
4. Deodhar, L. P., K. Saraswathi, and V. Varudkar. 1991 Aeromonas spp. and their association with human diarrheal disease J. Clin Microbiol. 29:863-866
5. Dryden, M., and R. Munro. 1989. Aeromonas septicemia: relation of species and clinical features. Pathology 21:111-114
6. Fainstein, V., S. Weaver, and G. P. Bodey. 1982 In vitro susceptibilities of Aeromonas hydrophila against new antibiotics Antimicroh. Agents Chemother. 22:513-514
7. Gold, W. L., and L. E. Salit. 1993. Aeromonas hydrophila infections of skin and soft tissue: report of 11 cases and review. Clin Infect. Dis. 16:69-74.
8. Iaconis, J. P., and C. C. Sanders. 1990. Purification and characterization of inducible β-lactamases in Aeromonas spp. Antimicrob. Agents Chemother. 34:44-51.
9. Janda, J. M., and R. Brenden. 1987. Importance of Aeromonas sobrta in Aeromonas bacteremia. J. Infect. Dis. 155:589-591
10. Janda, J. M., and P. S. Duffey. 1988. Mesophilic aeromonads in human disease: current taxonomy, laboratory identification, and infectious disease spectrum. Rev. Infect. Dis 10:980-996.
11. Ko, W. C., and Y. C. Chuang. 1995 Aeromonas bacteremia: review of 59 episodes. Clin. Infect. Dis 20:1298-1304.
12. Koehler, J. M., and L. R. Ashdown. 1993. In vitro susceptibilities of tropical strains of Aeromonas species from Queensland, Australia, to 22 antimicrobial agents. Antimicrob. Agents Chemother. 37:905-907.
13. Kuijper, E. J., and M. F. Peeters. 1991. Bacteriological and clinical aspects of Aeromonas-associated diarrhea in The Netherlands. Experientia 47:432-434
14. Morita, K. M., N. Watanabe, S. Kurata, and M. Kanamori. 1994. Betalactam resistance of motile Aeromonas isolates from clinical and environmental sources. Antimicrob. Agents Chemother. 38:353-355.
15. Motyl, M. R., G. McKinley, and J. M. Janda. 1985. In vitro susceptibilities of Aeromonas hydrophila, Aeromonas sobria, and Aeromonas caviae to 22 antimicrobial agents. Antimicrob. Agents Chemother 28:151-153.
16. Moyer, N. P. 1987. Clinical significance of Aeromonas species isolated from patients with diarrhea. J. Clin. Microbiol. 25:2044-2048.
17. Moyer, N. P., H. K. Geiss, M. Marinescu, A. Rigby, J. Robinson, and M. Altwegg. 1991. Media and methods for isolation of aeromonads from fecal specimens - a multilaboratory study Experientia 47:409-412.
18. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Document M7-A3, 3rd ed Approved standard Vol. 13, no 22. National Committee for Clinical Laboratory Standards, Villanova, Pa.
19. Tsai, W. C., C. H. Lee, and Y. C. Ju. 1986. Comparative study of the biotype, hemolysin-producing capability and antibiogram of the aquatic and the clinical strains of the Aeromonas, hydrophila. Chinese J. Microbiol. Immunol. 19: 124-135.
20. Vukmir, R. B. 1992. Aeromonas hydrophila: myofascial necrosis and sepsis. Intensive Care Med. 18:172-174.
21. Walsh, T. R., D. J. Payne, A. P. MacGowan, and P. M. Bennett. 1995. A clinical isolate of Aeromonas sobria with three chromosomally mediated inducible beta-lactamases: a cephalosprinase, a penicillinasc and a third enzyme, displaying carbapenemase activity. J Antimicrob. Chemother. 35: 271-279.